Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis

Research output: Contribution to journalReviewResearchpeer-review

Standard

Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis. / Rogers, Joseph M.

In: Frontiers in Molecular Biosciences, Vol. 7, 100, 2020.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Rogers, JM 2020, 'Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis', Frontiers in Molecular Biosciences, vol. 7, 100. https://doi.org/10.3389/fmolb.2020.00100

APA

Rogers, J. M. (2020). Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis. Frontiers in Molecular Biosciences, 7, [100]. https://doi.org/10.3389/fmolb.2020.00100

Vancouver

Rogers JM. Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis. Frontiers in Molecular Biosciences. 2020;7. 100. https://doi.org/10.3389/fmolb.2020.00100

Author

Rogers, Joseph M. / Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis. In: Frontiers in Molecular Biosciences. 2020 ; Vol. 7.

Bibtex

@article{95dd749de6fa44aba170e6b52e66910d,
title = "Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis",
abstract = "Many proteins and peptides fold upon binding another protein. Mutagenesis has proved an essential tool in the study of these multi-step molecular recognition processes. By comparing the biophysical behavior of carefully selected mutants, the concert of interactions and conformational changes that occur during folding and binding can be separated and assessed. Recently, this mutagenesis approach has been radically expanded by deep mutational scanning methods, which allow for many thousands of mutations to be examined in parallel. Furthermore, these high-throughput mutagenesis methods have been expanded to include mutations to non-canonical amino acids, returning peptide structure-activity relationships with unprecedented depth and detail. These developments are timely, as the insights they provide can guide the optimization of de novo cyclic peptides, a promising new modality for chemical probes and therapeutic agents.",
keywords = "cyclic peptides, deep mutational scanning, genetic code reprogramming, intrinsically disordered proteins (IDP), unnatural amino acids",
author = "Rogers, {Joseph M.}",
year = "2020",
doi = "10.3389/fmolb.2020.00100",
language = "English",
volume = "7",
journal = "Frontiers in Molecular Biosciences",
issn = "2296-889X",
publisher = "Frontiers Media",

}

RIS

TY - JOUR

T1 - Peptide Folding and Binding Probed by Systematic Non-canonical Mutagenesis

AU - Rogers, Joseph M.

PY - 2020

Y1 - 2020

N2 - Many proteins and peptides fold upon binding another protein. Mutagenesis has proved an essential tool in the study of these multi-step molecular recognition processes. By comparing the biophysical behavior of carefully selected mutants, the concert of interactions and conformational changes that occur during folding and binding can be separated and assessed. Recently, this mutagenesis approach has been radically expanded by deep mutational scanning methods, which allow for many thousands of mutations to be examined in parallel. Furthermore, these high-throughput mutagenesis methods have been expanded to include mutations to non-canonical amino acids, returning peptide structure-activity relationships with unprecedented depth and detail. These developments are timely, as the insights they provide can guide the optimization of de novo cyclic peptides, a promising new modality for chemical probes and therapeutic agents.

AB - Many proteins and peptides fold upon binding another protein. Mutagenesis has proved an essential tool in the study of these multi-step molecular recognition processes. By comparing the biophysical behavior of carefully selected mutants, the concert of interactions and conformational changes that occur during folding and binding can be separated and assessed. Recently, this mutagenesis approach has been radically expanded by deep mutational scanning methods, which allow for many thousands of mutations to be examined in parallel. Furthermore, these high-throughput mutagenesis methods have been expanded to include mutations to non-canonical amino acids, returning peptide structure-activity relationships with unprecedented depth and detail. These developments are timely, as the insights they provide can guide the optimization of de novo cyclic peptides, a promising new modality for chemical probes and therapeutic agents.

KW - cyclic peptides

KW - deep mutational scanning

KW - genetic code reprogramming

KW - intrinsically disordered proteins (IDP)

KW - unnatural amino acids

U2 - 10.3389/fmolb.2020.00100

DO - 10.3389/fmolb.2020.00100

M3 - Review

C2 - 32671094

AN - SCOPUS:85087669776

VL - 7

JO - Frontiers in Molecular Biosciences

JF - Frontiers in Molecular Biosciences

SN - 2296-889X

M1 - 100

ER -

ID: 245367295